AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A. Trowbridge -- Executive
AngioDynamics Inc.
-(ANGO)
XNAS:ANGO
Earnings calendar for the week of March 29
Encouraging data from the labor market and optimism brought on by the stimulus package bolstered stock markets this week. Benchmark indexes Dow
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive
AngioDynamics Inc. (ANGO) Q1 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Key highlights from AngioDynamics (ANGO) Q1 2021 earnings results
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by
Major earnings conferences to watch for the week of Sept. 28
Stock markets shifted to recovery mode as the week came to a close, with the major indices closing higher after staying in
AngioDynamics, Inc. (ANGO) Q4 2020 Earnings Call Transcript
AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the
AngioDynamics (NASDAQ: ANGO) Q2 2020 Earnings Call Transcript
AngioDynamics Inc (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer -- President, Chief Executive Officer, Director Steve Trowbridge -- Senior Vice
AngioDynamics (ANGO): Q2 2020 Earnings Snapshot
-- AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected. -- Net sales remained flat at
AngioDynamics misses Q3 earnings
AngioDynamics (NASDAQ: ANGO) posted third-quarter earnings on Tuesday before the regular trading hours. Net sales for the period increased 3% to $86.3 million,
AngioDynamics second-quarter results beat market estimates
AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million, with diluted
Companies reporting earnings this week: Jan 2 – 4
A slew of major companies are reporting earnings this week. Uniform provider UniFirst Corporation (UNF) will announce first-quarter earnings on Thursday before